J&J’s Clinical Data Disclosure Strategy Focuses On Collaboration With Yale University Group

In what appears to be the most expansive policy to date on release of clinical trial data, J&J will use an existing outside group and will share full clinical study reports and patient-level data regardless of when the studies were conducted.

More from Clinical Trials

More from R&D